HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Molecular response to imatinib in KIT F522C-mutated systemic mastocytosis.

AuthorsValerie Broderick, Katherine Waghorn, Stephen E Langabeer, Michael Jeffers, Nicholas C P Cross, Patrick J Hayden
JournalLeukemia research (Leuk Res) Vol. 77 Pg. 28-29 (02 2019) ISSN: 1873-5835 [Electronic] England
PMID30612056 (Publication Type: Case Reports, Letter)
Chemical References
  • Protein Kinase Inhibitors
  • Imatinib Mesylate
  • KIT protein, human
  • Proto-Oncogene Proteins c-kit
Topics
  • Aged
  • Female
  • Humans
  • Imatinib Mesylate (therapeutic use)
  • Mastocytosis, Systemic (drug therapy, genetics, pathology)
  • Mutation
  • Prognosis
  • Protein Kinase Inhibitors (therapeutic use)
  • Proto-Oncogene Proteins c-kit (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: